| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |